학술논문
Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England
Document Type
Article
Author
Source
In: ClinicoEconomics and Outcomes Research . (ClinicoEconomics and Outcomes Research, 2022, 14:231-247)
Subject
Language
English
ISSN
11786981